Public Company News

US FDA Study May Proceed letter for Clarity's Cu-64 SAR-bisPSMA trial in prostate cancer

SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has received a confirmation from the US Food and Drug Adm...

2022-02-07 22:08 2731

Pop Culture Group Announces Joint Venture to Create a First-ever Street Dance Chain SaaS Platform in China

New joint venture will accelerate the development of dance organizations in China XIAMEN, China, Feb. 7, 2022 /PRNewswire/ – Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-pop culture company inChina, announced today that a strategic partnership with an investo...

2022-02-07 22:00 2768

SmartKem, Inc. Begins Trading on the OTCQB in the US

Seeking to reshape the world of electronics with a revolutionary new organic semiconductor platform that enables a new generation of displays, sensors and logic MANCHESTER, England, Feb. 7, 2022 /PRNewswire/ -- SmartKem, Inc. (the Company) announced that its common stock has commenced trading on...

2022-02-07 21:27 3644

KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE

SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be presenting at the BIO CEO Conference, to be held in person and virtually inNew York, NY, from 14-17 Febr...

2022-02-07 21:00 3902

Origin Agritech Issues 2022 Guidance of 300% Revenue Growth

BEIJING, Feb. 7, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it expects revenues to grow in excess of 300%, to over150 million RMB, and expects to turn a profit for fiscal 2022. The expected revenue ...

2022-02-07 20:00 3775

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

INCHEON, South Korea, Feb. 7, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner of the 2022 CMO Leadership Awards presented by Outsourced Pharma and Life Science ...

2022-02-07 20:00 2837

Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant

* ASC10-A demonstrated strong in vitro antiviral activity against multiple SARS-CoV-2 virus variants including Omicron * By applying a double prodrug strategy, ASC10's permeability in Caco-2 cells and ASC10's oral bioavailability in monkeys were 3.2-fold and 2.3-fold of Molnupiravir, respecti...

2022-02-07 19:00 4353

Invitation to teleconference/audio transmission

GÖTEBORG, Sweden, Feb. 7, 2022 /PRNewswire/ -- Concordia Maritime welcomes you to participate in a teleconference/audio transmission onFebruary 10, 2022 at 3.00 pm CET. The session will feature a presentation of the Financial Statement for the full year 2021 and a Q&A session. Presiding: Erik ...

2022-02-07 18:46 2422

Clarivate Identifies Seven Medtech Trends to Watch in 2022

LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...

2022-02-07 16:00 2581

Sohu.com to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 22, 2022

BEIJING, Feb. 7, 2022 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video and game business group, will report its fourth quarter and fiscal year 2021 unaudited financial results onTuesday, February 22 , 2022, before U.S. market hours. Sohu's management team wil...

2022-02-07 13:00 4066

Haitong International included in FTSE4Good Index Series

HONG KONG, Feb. 6, 2022 /PRNewswire/ -- Haitong International Securities Group Limited ("Haitong International" or "The Group"; Stock Code: 665.HK) announced today that the Group has been included in the FTSE4Good Index by global index provider FTSE Russell, which is owned by the London Stock Exc...

2022-02-07 12:36 3275

New "Captain Tsubasa: Dream Team" Dream Championship Rating System

TOKYO, Feb. 7, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Team introduced a new Rating System for the Dream Championship worldwide tournament starting fromFriday, February 4. See the original pres...

2022-02-07 11:15 3802

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037

SHANGHAI and HONG KONG, Feb. 7, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and o...

2022-02-07 08:30 3937

Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer

SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia...

2022-02-07 08:00 5239

Splitit Announces Step-Change MSV to Complete a Record Year in Q4 FY21 Quarterly Report & Appendix 4C

- Record Merchant Sales Volume (MSV) of US$130M up 51% Year on Year (YoY) and up 40% Quarter on Quarter (QoQ) - MSV driven by strong performance in APAC, specifically Japan, record MSV over Black Friday and Cyber Monday and significant contribution from the Christmas shopping period  - FY21 MSV...

2022-02-07 07:14 3770

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

* The objectives of the U.S. Phase I trial are to find a recommended Phase II dose and obtain preliminary efficacy in patients with advanced solid tumors * The first U.S. patient is expected to be dosed in the first half of 2022 * ASC61 shows significant antitumor efficacy as a single agent i...

2022-02-06 18:30 5267

SHIKIGaku Co., Ltd. (7049, TSE Mothers) Performance for the nine months ended november 30, 2021

TOKYO, Feb. 4, 2022 /PRNewswire/ -- Bolstered by substantial growth in SHIKIGAKU Basic Services, the Company maintained significant increases in sales and profit in the nine months endedNovember 30, 2021. Summary of results During the nine months ended November 30, 2021, the Japanese economic ou...

2022-02-06 12:01 3026

Crunchfish Digital Cash for CBDC - with all desired features a Central Bank could ask for

STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Crunchfish Digital Cash is ideally suited for retail CBDC as it caters to all desired features that a Central Bank could ever ask for. Crunchfish Digital Cash for CBDC was the topic of the fifth Survival of the fittest webinar onFebruary 4th, 2022. The we...

2022-02-04 22:42 4748

Senmiao Technology Launches Ride-Hailing Platform in Haikou, the Provincial Capital of Hainan Province

CHENGDU, China, Feb. 4, 2022 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focusing on the online ride-hailing industry inChina as well as an operator of its own online ride-hailing platform, today announced the launch of...

2022-02-04 22:00 5759

AP Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing February 7, 2022

NEW YORK, Feb. 4, 2022 /PRNewswire/ -- AP Acquisition Corp (the NYSE: APCA-U) (the "Company") announced today that, commencingFebruary 7, 2022, holders of the units sold in the Company's initial public offering of 17,250,000 units, closed onDecember 21, 2021, may elect to separately trade the Cla...

2022-02-04 19:32 5531